Share-based Payment Arrangement, Expense of 60 DEGREES PHARMACEUTICALS, INC. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
60 DEGREES PHARMACEUTICALS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • 60 DEGREES PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $79,000, a 88% decline year-over-year.
  • 60 DEGREES PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $406,021.
  • 60 DEGREES PHARMACEUTICALS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $3,608,648, a 108% increase from 2023.
  • 60 DEGREES PHARMACEUTICALS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $1,736,174.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

60 DEGREES PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $406,021 $79,000 -$589,974 -88% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $995,995 $78,620 -$2,674,048 -97% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $3,670,043 $186,763 +$61,395 +49% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $3,608,648 $61,638 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $668,974 +$119,943 +22% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $2,752,668 +$2,474,085 +888% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $125,368 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q3 2023 $549,031 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $278,583 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2

60 DEGREES PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,608,648 +$1,872,474 +108% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $1,736,174 +$1,736,174 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $0 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.